Is a respiratory variation in the transthoracic (TR) gradient of greater than 50% normal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A respiratory variation in the tricuspid regurgitation (TR) gradient greater than 50% is considered a normal physiological phenomenon. This finding is a common occurrence that happens due to the influence of respiration on right heart hemodynamics, as described in the 2014 AHA/ACC guideline for the management of patients with valvular heart disease 1. During inspiration, negative intrathoracic pressure increases venous return to the right heart, which can temporarily increase the TR gradient. Conversely, during expiration, the TR gradient typically decreases. This normal respiratory variation reflects the right ventricle's sensitivity to changes in preload and is an expected finding during echocardiographic assessment. Some key points to consider when evaluating TR include:

  • The integrative assessment of multiple parameters to characterize the severity of TR, as recommended by the ASE and EAE 1
  • The measurement of tricuspid annular diameter in the apical 4-chamber view to distinguish primary from functional TR 1
  • The estimation of pulmonary artery systolic pressure from the maximal tricuspid valve regurgitant velocity 1 Clinicians should be concerned only when this variation occurs alongside other abnormal findings such as right ventricular dilation, elevated right atrial pressure, or signs of right heart failure, as outlined in the stages of TR (Table 19) 1. Understanding this normal physiological response helps avoid misinterpretation of TR measurements and prevents unnecessary additional testing or interventions based solely on respiratory TR gradient variations.

From the Research

Respiratory Variation in TR Gradient

  • The concept of respiratory variation in tricuspid regurgitation (TR) gradient is supported by a study published in 2010 2, which found that expiration to inspiration changes affected TR peak velocity, duration, and time-velocity integral.
  • The study demonstrated that inspiratory TR augmentation was characterized by increased effective regurgitant orifice and volume, despite a decreased TR driving force.
  • The pathophysiology of TR is complex and dynamic, with almost universal respiratory changes of large magnitude, as noted in the 2010 study 2.

Clinical Implications

  • A respiratory variation in the TR gradient of greater than 50% may be considered abnormal, as it suggests that the TR is influenced by changes in respiration, which is consistent with the findings of the 2010 study 2.
  • The diagnosis and treatment of TR, including the assessment of respiratory dependence, are crucial in managing the disease, as highlighted in studies published in 2022 3 and 2023 4.
  • Transcatheter therapies, such as edge-to-edge repair, are emerging as promising solutions for patients with severe TR, as discussed in studies published in 2017 5 and 2022 6.

Key Findings

  • The 2010 study 2 found that effective regurgitant orifice changes during inspiration were independently linked to inspiratory annular enlargement and right ventricular shape widening with increased valvular tenting.
  • The study published in 2022 6 emphasized the importance of understanding the valvular/ventricular anatomy and disease pathophysiology in determining appropriate management solutions for TR.
  • The 2023 study 4 highlighted the need for detailed morphological and mechanistic assessment of the tricuspid valve using transthoracic and transesophageal imaging to optimize patient selection and procedural success for transcatheter edge-to-edge repair.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tricuspid valve regurgitation: current diagnosis and treatment.

American journal of cardiovascular disease, 2022

Research

Key Echocardiographic Considerations for Tricuspid Valve Transcatheter Edge-to-Edge Repair.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2023

Research

Emerging Transcatheter Options for Tricuspid Regurgitation.

Methodist DeBakey cardiovascular journal, 2017

Related Questions

Does my child with congenital ventricular septal defect and mild tricuspid (tri-cuspid valve) regurgitation require surgical closure of the defect and valve repair or should we wait for further development?
What is the significance of a normal respiratory structure with a greater than 50% tricuspid regurgitation (TR) gradient, trivial tricuspid regurgitation, and a right ventricular systolic pressure (RVSP) of 3mmHg, with an inferior vena cava (IVC) calibre of 1.3 cm and a tricuspid regurgitation velocity of 1.2 meters per second?
What is the management of severe tricuspid regurgitation (TR) with right ventricular (RV) dysfunction?
What does a respiratory variation in the Transverse Relaxation (TR) gradient greater than 50% indicate?
What is the significance of a 50% variation in Respiratory Variation (RESP) on the tricuspid valve?
What is the diagnosis for a 5-month-old female presenting with poor feeding, chronic diarrhea, umbilical hernia, macrocephaly, bulging frontal bones, coarse facies, hepatosplenomegaly, corneal opacification, recurrent otitis (ear infections), weak eyesight, joint stiffness, respiratory infections, and increased urinary excretion of heparan sulfate and dermatan sulfate?
What is the treatment for Angioedema (Angioneurotic Edema)?
What is the next step in managing a 38-year-old patient with persistent wheezing and mild basal crackles, diagnosed with acute bronchitis 3 days ago, and currently treated with amoxicillin (amoxicillin) + clavulanic acid (clavulanic acid), salbutamol (albuterol) every 4 hours, and beclomethasone (beclomethasone) every 12 hours, with a history of obesity and no other comorbidities?
What is the recommended dosage of epinephrine (adrenaline) for treating hypotension (low blood pressure) associated with shock?
What is the treatment for nicotine (Nicotinic Acetylcholine Receptor agonist) overdose?
What is the clinical significance of a normal tricuspid valve structure with greater than 50% respiratory variation in the Tricuspid Regurgitation (TR) gradient, no stenosis, normal Inferior Vena Cava (IVC) calibre, trivial Right Ventricular Systolic Pressure (RVSP) regurgitation, normal Right Atrial (RA) pressure, and trivial Tricuspid Regurgitation (TR) velocity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.